(Q38058339)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23134073%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

title

Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23134073%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23134073%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

author name string

Y C Woo

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23134073%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Aimin Xu

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23134073%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Karen S L Lam

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23134073%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

publication date

1 April 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23134073%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

published in

Clinical Endocrinology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23134073%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

volume

78

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23134073%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23134073%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

page(s)

489-496

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23134073%20AND%20SRC:MED&resulttype=core&format=json

Evolution of the Fgf and Fgfr gene families

17 February 2020

cites work

1 reference

21 January 2018

1 reference

Identification of a novel FGF, FGF-21, preferentially expressed in the liver

21 January 2018

1 reference

Research resource: Comprehensive expression atlas of the fibroblast growth factor system in adult mouse.

21 January 2018

1 reference

Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21

21 January 2018

1 reference

Fibroblast growth factor-21 regulates PPARγ activity and the antidiabetic actions of thiazolidinediones.

21 January 2018

1 reference

FGF-21 as a novel metabolic regulator

21 January 2018

1 reference

The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21.

21 January 2018

1 reference

Forced expression of hepatocyte-specific fibroblast growth factor 21 delays initiation of chemically induced hepatocarcinogenesis.

21 January 2018

1 reference

Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans

21 January 2018

1 reference

High plasma level of fibroblast growth factor 21 is an Independent predictor of type 2 diabetes: a 5.4-year population-based prospective study in Chinese subjects

21 January 2018

1 reference

Obesity is a fibroblast growth factor 21 (FGF21)-resistant state

21 January 2018

1 reference

Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states

21 January 2018

1 reference

PPARalpha is a key regulator of hepatic FGF21.

21 January 2018

1 reference

Thermogenic activation induces FGF21 expression and release in brown adipose tissue.

21 January 2018

1 reference

The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man.

21 January 2018

1 reference

Paradoxical regulation of human FGF21 by both fasting and feeding signals: is FGF21 a nutritional adaptation factor?

21 January 2018

1 reference

Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity.

21 January 2018

1 reference

Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity

21 January 2018

1 reference

Fibroblast growth factor 21 action in the brain increases energy expenditure and insulin sensitivity in obese rats

21 January 2018

1 reference

The fasting polypeptide FGF21 can enter brain from blood

21 January 2018

1 reference

FGF-21/FGF-21 receptor interaction and activation is determined by betaKlotho

21 January 2018

1 reference

Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways.

21 January 2018

1 reference

Molecular determinants of FGF-21 activity-synergy and cross-talk with PPARgamma signaling

21 January 2018

1 reference

FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response

21 January 2018

1 reference

Integrated regulation of hepatic metabolism by fibroblast growth factor 21 (FGF21) in vivo

21 January 2018

1 reference

Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis

21 January 2018

1 reference

Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver.

21 January 2018

1 reference

Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease

21 January 2018

1 reference

Growth hormone induces hepatic production of fibroblast growth factor 21 through a mechanism dependent on lipolysis in adipocytes

21 January 2018

1 reference

FGF21 attenuates lipolysis in human adipocytes - a possible link to improved insulin sensitivity

21 January 2018

1 reference

Circadian rhythm of circulating fibroblast growth factor 21 is related to diurnal changes in fatty acids in humans.

21 January 2018

1 reference

Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice

21 January 2018

1 reference

Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis

21 January 2018

1 reference

Free fatty acids link metabolism and regulation of the insulin-sensitizing fibroblast growth factor-21.

21 January 2018

1 reference

Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance.

21 January 2018

1 reference

Effects of short-term continuous subcutaneous insulin infusion on fasting plasma fibroblast growth factor-21 levels in patients with newly diagnosed type 2 diabetes mellitus

21 January 2018

1 reference

Serum levels of FGF-21 are increased in coronary heart disease patients and are independently associated with adverse lipid profile

21 January 2018

1 reference

Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride

21 January 2018

1 reference

Serum fibroblast growth factor 21 levels in polycystic ovary syndrome

21 January 2018

1 reference

TNF-α represses β-Klotho expression and impairs FGF21 action in adipose cells: involvement of JNK1 in the FGF21 pathway

21 January 2018

1 reference

Plasma concentrations of fibroblast growth factors 19 and 21 in patients with anorexia nervosa.

21 January 2018

1 reference

Fibroblast growth factor-21 may mediate growth hormone resistance in anorexia nervosa

21 January 2018

1 reference

Inhibition of growth hormone signaling by the fasting-induced hormone FGF21.

21 January 2018

1 reference

Fibroblast growth factor 21 reduces the severity of cerulein-induced pancreatitis in mice

21 January 2018

1 reference

Serum levels of the adipokine FGF21 depend on renal function

21 January 2018

1 reference

Circulating FGF21 levels are progressively increased from the early to end stages of chronic kidney diseases and are associated with renal function in Chinese

21 January 2018

1 reference

Association between serum fibroblast growth factor 21 and diabetic nephropathy.

21 January 2018

1 reference

Effects of rosiglitazone on fasting plasma fibroblast growth factor-21 levels in patients with type 2 diabetes mellitus

21 January 2018

1 reference

Dynamic change of serum FGF21 levels in response to glucose challenge in human.

21 January 2018

1 reference

Relationship of serum fibroblast growth factor 21 with abnormal glucose metabolism and insulin resistance: the Baltimore Longitudinal Study of Aging

21 January 2018

1 reference

Fibroblast growth factor 21 corrects obesity in mice

21 January 2018

1 reference

FGF21 analogs of sustained action enabled by orthogonal biosynthesis demonstrate enhanced antidiabetic pharmacology in rodents

21 January 2018

1 reference

Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor γ.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/CEN.12095

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23134073%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23134073%20AND%20SRC:MED&resulttype=core&format=json